A Study of YL202 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer and Breast Cancer
Phase: 1
Status: Ongoing
About
A Study of YL202 in Patients With Locally Advanced or Metastatic Non-small Cell Lung
Cancer and Breast Cancer.
Details
A Phase 1, Multicenter, Open-label, First-in-human Study of YL202 in Patients With
Locally Advanced or Metastatic Non-small Cell Lung Cancer and Breast Cancer.
Sponsor: MediLink Therapeutics
NCT05653752